Switzerland's financial regulator FINMA has approved the country's first retail Bitcoin ETF, permitting a regulated fund to invest directly in Bitcoin. This marks a significant step as the ETF targets the general public, unlike previous crypto funds limited to qualified investors. FINMA granted an exception to diversification rules due to Bitcoin's liquidity and trading history but requires strict custody controls and clear investor risk warnings. The approval highlights growing demand for regulated crypto products, though FINMA cautions investors about Bitcoin's price volatility and potential losses. Details on the fund's issuer and launch date remain undisclosed.
Switzerland's approval of its first retail Bitcoin ETF comes as 42 out of 50 major cryptocurrencies on Pluang rose today. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 20, 2026 23:21 WIB: AXS (Axie Infinity) rose 3.77% to Rp18.667 with 69% buy orders, SNX (Synthetix) increased 3.39% to Rp3.999 despite 99% sell orders, and EGLD (MultiversX) gained 3.23% to Rp67.053 with 57% buy orders. Typical hold times range from 62 to 86 days across these assets.
Synchrony Financial reported Q3 2026 earnings per share of $2.68 and revenue of $4.91 billion, both exceeding analyst expectations. However, net profit fell to $892 million from $1.1 billion the previous year due to higher operating costs, even as cr...
Hancock Whitney is set to report its Q3 2026 earnings on October 20, with analysts forecasting earnings per share between $1.65 and $1.66 and revenue estimates from $418.85 million to $422 million. Despite year-over-year growth projections, indicator...
In September 2026, New York State's housing inventory increased by 9.8% year-over-year, reaching 35,294 homes available for sale. Despite this rise in supply, home prices continued to grow, with the median sales price up 5.9% to $450,000 compared to ...
The Europe Electronic Health Record (EHR) market is projected to grow from $8.05 billion in 2024 to $15.37 billion by 2031, at a compound annual growth rate of 9.9%. Growth is fueled by increasing EHR adoption, government digital health programs, and...
EssilorLuxottica reported a 9.0% increase in revenue for Q3 2026, reaching €7,486 million, with a 7.2% rise at constant exchange rates. Growth was broad-based, with strong double-digit increases in Asia-Pacific and the Direct to Consumer segment up 1...
